We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.25M Turnover 0%
1-Year Est. Return 26.51%
This Fund
S&P 500
This Quarter Est. Return
-5.65%
1 Year Est. Return
-26.51%
3 Year Est. Return
-47.48%
5 Year Est. Return
-89.34%
10 Year Est. Return
–
AUM
$1.25M
AUM Growth
-$233K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
4.9 years
Top 10 Avg Time Held
4.9 years
Top 20 Avg Time Held
4.9 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TCRX icon
1
TScan Therapeutics
TCRX
$11.8M
$617K 49.27%
630,000
– –
2021 Q3
19 quarters
BRNS
2
DELISTED
Barinthus Biotherapeutics
BRNS
$424K 33.82%
642,204
– –
2021 Q2
20 quarters
HOWL icon
3
Werewolf Therapeutics
HOWL
$47.9M
$212K 16.92%
589,102
– –
2021 Q2
20 quarters

Similar funds

DC Funds's Q2 2026 Portfolio in Review

As of Q2 2026, DC Funds held 3 positions worth $1.25M, down 16% from $1.49M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $1.25M portfolio in Q2 2026.
  • DC Funds opened 0 new positions and closed 0 in Q2 2026.
  • DC Funds's portfolio value fell 16% quarter-over-quarter to $1.25M.

Based on DC Funds's 13F filing for Q2 2026, filed 14 Aug 2026.